camptothecin has been researched along with tocopherols in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghazwani, M; Huang, Y; Li, S; Liu, C; Lu, J; Ma, X; Wang, P; Xu, J; Zhang, P | 1 |
| Alferiev, IS; Brodeur, GM; Chorny, M; Fishbein, I; Guan, P; Guerrero, DT; Kolla, V; Nguyen, F; Pressly, BB; Soberman, D | 1 |
2 other study(ies) available for camptothecin and tocopherols
| Article | Year |
|---|---|
The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Survival; Diffusion; Drug Compounding; Drug Stability; Drug Synergism; Mice; Nanocapsules; Particle Size; Prodrugs; Tocopherols; Treatment Outcome | 2015 |
Nanocarrier-Based Delivery of SN22 as a Tocopheryl Oxamate Prodrug Achieves Rapid Tumor Regression and Extends Survival in High-Risk Neuroblastoma Models.
Topics: Camptothecin; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Drug Delivery Systems; Humans; Nanoparticles; Neuroblastoma; Prodrugs; Risk Factors; Survival Analysis; Tocopherols; Xenograft Model Antitumor Assays | 2022 |